Search research articles
Contact Us
Filters
Showing results (1431-1440 of 1,535) with videos related to
Page
of 154
Sort By:
Communications Biology
|
June 27, 2026
SMPD3 suppresses oligodendroglioma growth via dual autocrine-paracrine roles
Fermisk Saleh, Anjali Balakrishnan, Lata Adnani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 2019
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments
Yaoqing Shen, Cameron J Grisdale, Sumaiya A Islam, et al.
Nature Genetics
|
June 30, 2009
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
Mark M Pomerantz, Nasim Ahmadiyeh, Li Jia, et al.
The New England Journal of Medicine
|
October 17, 2008
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Yujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
Antonio Omuro, Kathryn Beal, Philip Gutin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
Antonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Nature Communications
|
November 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Treg Grubb, Pooneh Koochaki, Sayed Matar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
Jaydira Del Rivero, Kimberly Perez, Erin B Kennedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG
Holly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Page
of 154
Search research articles
Search
Showing results (1431-1440 of 1,535) with videos related to
Sort By:
Page
of 154
Communications Biology
|
June 27, 2026
SMPD3 suppresses oligodendroglioma growth via dual autocrine-paracrine roles
Fermisk Saleh, Anjali Balakrishnan, Lata Adnani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 2019
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments
Yaoqing Shen, Cameron J Grisdale, Sumaiya A Islam, et al.
Nature Genetics
|
June 30, 2009
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
Mark M Pomerantz, Nasim Ahmadiyeh, Li Jia, et al.
The New England Journal of Medicine
|
October 17, 2008
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Yujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
Antonio Omuro, Kathryn Beal, Philip Gutin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
Antonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
S A Hurvitz, S Loi, J O'Shaughnessy, et al.
Nature Communications
|
November 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Treg Grubb, Pooneh Koochaki, Sayed Matar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
Jaydira Del Rivero, Kimberly Perez, Erin B Kennedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG
Holly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Page
of 154